ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)
$60.71 -2.04 (-3.251%)
Analysed ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) News Sources
ARWR Stock Heads For Worst Day In Over A Year Despite Positive Cholesterol Drug Data — Is This A ‘Sell The News’ Move?
15-09-2026
stocktwits.com
Arrowhead Achieves Clinical Validation for New Drug Platform
16-09-2026
yahoo.com
Not A ‘Gangbusters Launch’ — Arrowhead Predicts Slow Burn to $3B-$4B Peak For Redemplo, Highlights ‘Massive Pipeline’
16-09-2026
stocktwits.com
RNA Interference Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, and Silence Therapeutics
18-09-2026
yahoo.com
Arrowhead Pharmaceuticals Eyes SHTG Filing as RNAi Pipeline Expands
18-09-2026
marketbeat.com
Arrowhead Pharmaceuticals Spotlights Dual-Target RNAi Data, Plozasiran Launch Progress
19-09-2026
marketbeat.com
Arrowhead Pharmaceuticals (ARWR) On ARO DIMER PA Data And Whether Undervaluation Still Holds
19-09-2026
yahoo.com
ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near
24-09-2026
stocktwits.com
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
29-09-2026
yahoo.com
Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia
07-10-2026
yahoo.com
What is the current price of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The current price of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is $60.71.
ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) since the previous trading day is $-2.04.
ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) since the previous trading day is -3.251%.
What is the most recent average sentiment score for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The most recent average sentiment score for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)?
The most recent sentiment for ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ) is .
SEC-8K** Filing Available For ARROWHEAD PHARMACEUTICALS IN (ARWR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.